Scarica l'app Stockscreener
22.99
1.50%
-0.35
Dopo l'orario di chiusura:
22.99
Precedente Chiudi:
$23.34
Aprire:
$23.72
Volume 24 ore:
815.51K
Relative Volume:
0.68
Capitalizzazione di mercato:
$2.39B
Reddito:
$71.78M
Utile/perdita netta:
$-295.28M
Rapporto P/E:
-7.276
EPS:
-3.1597
Flusso di cassa netto:
$-271.85M
1 W Prestazione:
-0.09%
1M Prestazione:
-10.96%
6M Prestazione:
+48.23%
1 anno Prestazione:
+153.19%
Intervallo 1D:
$22.85
$23.75
Intervallo di 1 settimana:
$22.41
$23.98
Portata 52W:
$8.99
$28.23
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Nome
Nurix Therapeutics Inc
Settore
Industria
Telefono
(415) 660-5320
Indirizzo
1600 SIERRA POINT PKWY, BRISBANE
Compare NRIX vs VRTX, MRNA, REGN, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
22.99 | 2.39B | 71.78M | -295.28M | -271.85M | -3.1597 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-08 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-24 | Ripresa | Truist | Buy |
| 2025-10-21 | Iniziato | Mizuho | Outperform |
| 2025-03-17 | Iniziato | Leerink Partners | Market Perform |
| 2024-12-10 | Iniziato | BTIG Research | Buy |
| 2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-11 | Iniziato | Jefferies | Buy |
| 2024-09-06 | Ripresa | Robert W. Baird | Outperform |
| 2024-07-31 | Iniziato | Truist | Buy |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-03-09 | Iniziato | Barclays | Overweight |
| 2023-02-28 | Iniziato | Oppenheimer | Outperform |
| 2022-10-11 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | Iniziato | Wells Fargo | Equal Weight |
| 2021-12-29 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-14 | Iniziato | SVB Leerink | Outperform |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2021-04-30 | Ripresa | Piper Sandler | Overweight |
| 2021-04-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-04-14 | Iniziato | Berenberg | Buy |
| 2020-11-19 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-18 | Iniziato | JP Morgan | Overweight |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2020-08-18 | Iniziato | Piper Sandler | Overweight |
| 2020-08-18 | Iniziato | Stifel | Buy |
Mostra tutto
Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie
Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock? - Zacks Investment Research
Nurix Therapeutics (NRIX) Projected to Post Earnings on Thursday - MarketBeat
Nurix Therapeutics, Inc. (NRIX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer - Investing News Network
Nurix receives $7 million milestone payment from Pfizer collaboration - grafa.com
Pfizer will pay Nurix another $7 million, bringing its total receipts to $82 million. - Stock Titan
PERCEPTIVE ADVISORS LLC Adds Nurix Therapeutics Inc (NRIX) -- Sh - GuruFocus
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Stock Has Consensus Price Target of $34.21 According to Analysts - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Upgraded to "Hold" at Wall Street Zen - MarketBeat
842,089 Shares in Nurix Therapeutics, Inc. $NRIX Bought by Bank of America Corp DE - MarketBeat
Nurix Therapeutics (NRIX) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
More than 5% of Nurix Therapeutics (NRIX) is reported by three parties, but one fund holds the shares. - Stock Titan
Trading Systems Reacting to (NRIX) Volatility - Stock Traders Daily
Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Biotech Gem With A 33% Upside Potential - DirectorsTalk Interviews
Behavioral Patterns of NRIX and Institutional Flows - Stock Traders Daily
Nurix Therapeutics Stock Price Forecast. Should You Buy NRIX? - StockInvest.us
We Think Nurix Therapeutics (NASDAQ:NRIX) Can Afford To Drive Business Growth - Moomoo
Nurix Therapeutics, Inc. (NRIX) Latest Stock News & Headlines - Yahoo Finance
Here's Why You Should Add NRIX Stock to Your Portfolio Now - Yahoo Finance
Transcript : Nurix Therapeutics, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 03 - marketscreener.com
Nurix Therapeutics (NRIX) Upgraded to Buy: Here's Why - Yahoo Finance
Nurix Therapeutics (NRIX) Advances 0.50% to $26.26 as Shares Test Range Between Support and ResistanceBreakout Confirmation - careplusvn.com
Nurix Therapeutics at Wells Fargo conference: pipeline, deal momentum By Investing.com - Investing.com India
Nurix Therapeutics at Wells Fargo conference: pipeline, deal momentum - investing.com
Legal & General Group Plc Buys Shares of 72,026 Nurix Therapeutics, Inc. $NRIX - MarketBeat
Wall Street Zen Downgrades Nurix Therapeutics (NASDAQ:NRIX) to Sell - MarketBeat
Bank of New York Mellon Corp Purchases New Shares in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics chief legal officer sells over $149k in shares By Investing.com - Investing.com South Africa
Braidwell LP Cuts Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Nurix Therapeutics chief legal officer sells over $149k in shares - Investing.com
The Manufacturers Life Insurance Company Acquires New Holdings in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Man Group plc Makes New $2.08 Million Investment in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Alyeska Investment Group L.P. Takes $3.35 Million Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix CSO Gwenn Hansen sells $36,982 in stock - Investing.com
Nurix Therapeutics (NASDAQ:NRIX) Insider Gwenn Hansen Sells 1,452 Shares of Stock - MarketBeat
Nurix Therapeutics to Participate in Upcoming September Investor Conferences - Investing News Network
BlackRock Inc. Buys New Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Deutsche Bank AG Takes Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
58,898 Shares in Nurix Therapeutics, Inc. $NRIX Bought by Polymer Capital Management HK LTD - MarketBeat
Nurix Therapeutics: Roche Has Changed The Economics Of The Bull Case (NASDAQ:NRIX) - Seeking Alpha
Bank of America Corp DE Purchases 65,595 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer - Sahm
Edmond DE Rothschild Holding S.A. Invests $2.18 Million in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix (NRIX) Price: Ends Lower by 1.22% at $26.72 on the Day; Current Setup: Traders Can Monitor the $25.38-$28.06 Range in the Available RecordSector Neutral Pair - careplusvn.com
Deep Track Capital, LP Expands Nurix Therapeutics Inc (NRIX) Sta - GuruFocus
Top BridgeBio Oncology Therapeutics (BBOT) Competitors 2026 - MarketBeat
Press Release: Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer - Moomoo
Nurix Therapeutics (NASDAQ:NRIX) Reaches New 12-Month HighShould You Buy? - MarketBeat
Nurix (NRIX) Results Review: The EPS Result Is Below Expectation for the Current Session; Post-Earnings: Shares Fall 0.88%EPS Growth Rate - Vinanet
Nurix Therapeutics (NRIX) Starts Phase 3 And Lands Sanofi Milestone, Is The Valuation About Right? - Sahm
Nurix Therapeutics Inc Azioni (NRIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Nurix Therapeutics Inc Azioni (NRIX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Ring Christine | Chief Legal Officer |
Sep 02 '26 |
Sale |
25.76 |
5,787 |
149,072 |
9,110 |
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):